🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is — my results so far Page 4

Can we talk about how SLOW the FDA is — my results so far

NurseAsh_DET Tue, Nov 18, 2025 at 7:47 PM 43 replies 1,294 viewsPage 4 of 9
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Nov 29, 2025 at 3:09 PM#16

Clinical perspective, offered as context rather than as advice. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Last edited: Nov 29, 2025 at 6:09 PM
5 3Dr.ObesityLA, NurseKim_ATL, paul_denver and 2 others
Reply Quote Save Share Report
sarah_nash92
Member
712
3,123
Jun 2024
Nashville, TN
Dec 1, 2025 at 5:24 AM#17
Dr.PulmRoch said:
One habit that pays for itself: post the method alongside the number.

That reframing is the part I needed.

6 4JakeSmashed95, NauseaFreeNow, SteveThurs and 3 others
Reply Quote Save Share Report
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Dec 2, 2025 at 7:40 PM#18

From the other side of the consultation, briefly. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

7 5gary_naperville, sean_dublin, hannah_MT and 4 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Dec 4, 2025 at 9:54 AM#19
sean_dublin said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

Adding a me-too, because a thread of one person's experience is not much use. The detail I would add is minor and it is already implied above.

8 6TomTeleRx, DoseLogDan, SleepFixSam and 5 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Dec 6, 2025 at 12:08 AM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Thread quality here is what the rules are for. Keep it up.

30 3PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 27 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register